Latest News
A research team co-led by Yale School of Public Health professor Dr. Sunil Parikh, MD, MPH, has received $500,000 in funding from the Bill & Melinda Gates Foundation to continue the development of an innovative noninvasive test for malaria using lasers and ultrasound.
- August 27, 2021Source: Yale School of Public Health
Residents in long-term care facilities had a significantly higher rate of reinfection than people in the general population.
- March 15, 2021Source: YaleNews
In what is believed to be the first published study of COVID-19 vaccine effectiveness in long-term care facilities such as nursing homes, a research team co-led by the Yale School of Public Health found a widely used vaccine is highly successful in preventing infections.
- August 18, 2020Source: US News
When COVID-19 was raging in the Northeastern United States, more than 25% of Connecticut nursing-home residents were suffering from the coronavirus, a new survey reports.
- August 12, 2020Source: Yale News
A new study by the Yale School of Public Health finds that 28% of recently surveyed Connecticut nursing home residents tested positive for coronavirus. Most of the patients were asymptomatic.
- July 16, 2020Source: AARP
Start with changes to staffing policies, these experts say
- May 08, 2020Source: STAT
Although much of the nation’s focus has been on the surge of Covid-19 cases and deaths in New York and other large cities, the overlooked epicenter of the pandemic is our nation’s nursing homes, veterans’ homes, and other long-term care facilities.
- March 18, 2019
Childhood malaria episodes could be reduced by 20% during malaria transmission season if an entire village population were given the mosquito-killing drug ivermectin or IVM every three weeks, according to a new study published in The Lancet international medical journal.
- November 01, 2018
Malaria continues to exact a tremendous toll on resource-limited regions. In 2016 alone, there were an estimated 216 million cases worldwide, resulting in 445,000 deaths.
- June 12, 2018Source: AAAS and EurekAlert!
Current recommended dosing regimens for the most widely used treatment for uncomplicated Plasmodium falciparum malaria may be sub-optimal for the most vulnerable populations of patients, according to a study published this week in PLOS Medicine.